When should a patient with elevated serum creatinine be referred to a nephrologist, and which tests should be obtained before referral?

When to Refer Patients with Elevated Creatinine to Nephrology

Refer patients to a nephrologist when eGFR falls below 30 mL/min/1.73 m² (CKD stage G4-G5), when there is significant albuminuria (ACR ≥300 mg/g or ≥30 mg/mmol), or when there is an acute or sustained decline in kidney function that is unexplained or progressive. 1

Clear Indications for Nephrology Referral

Absolute Referral Criteria

• eGFR <30 mL/min/1.73 m² (stages G4-G5), though stable isolated findings may only require specialist advice rather than formal ongoing management 1
• Acute kidney injury (AKI) or abrupt sustained fall in GFR, particularly when creatinine increases ≥0.3 mg/dL within 48 hours or rises to ≥1.5 times baseline within 7 days 1
• Significant albuminuria: ACR ≥300 mg/g (≥30 mg/mmol) or protein excretion >1 g/day 1, 2
• Progressive CKD: eGFR decline >20% on subsequent testing or doubling of ACR 3
• Resistant hypertension requiring ≥4 antihypertensive agents 1
• Persistent electrolyte abnormalities, particularly potassium 1
• Hematuria with RBCs >20 per high-power field sustained and unexplained, or urinary red cell casts 1
• Hereditary kidney disease 1
• Recurrent or extensive nephrolithiasis 1

Risk-Based Referral Thresholds

Use validated kidney failure risk calculators (such as the Kidney Failure Risk Equation) to guide referral timing: a 5-year kidney failure risk of 3-5% warrants nephrology referral in addition to eGFR/albuminuria criteria 3

Pre-Referral Testing Requirements

Essential Laboratory Tests

Before referring, obtain the following to optimize specialist consultation:

• Serum creatinine with calculated eGFR (using CKD-EPI equation preferred) 4
• Urinalysis with microscopy to assess for casts, RBCs, and cellular elements 5
• Urine albumin-to-creatinine ratio (ACR) or protein-to-creatinine ratio (PCR) on spot urine sample 1, 4
• Complete metabolic panel including electrolytes (sodium, potassium, bicarbonate), calcium, phosphorus 4
• Complete blood count to assess for anemia 4
• Hemoglobin A1c if diabetic or diabetes suspected 4
• Lipid panel 4

Additional Investigations for eGFR 30-60 mL/min/1.73 m²

For patients with moderate CKD (G3a-G3b), also obtain:

• Parathyroid hormone (PTH) level 4
• 25-hydroxyvitamin D level 4
• Renal ultrasound if obstruction, structural abnormality, or hereditary disease suspected 1

Medication Review

Document all current medications, particularly:

• NSAIDs, which should be discontinued 6, 1
• Nephrotoxic agents including contrast media exposure 6, 5
• ACE inhibitors/ARBs and current doses 1
• Diuretics 7
• Over-the-counter medications, herbals, and supplements 5

Special Circumstances Requiring Earlier or Urgent Referral

Urgent Nephrology Consultation Needed

• Creatinine ≥3 times baseline or ≥4.0 mg/dL 5
• Abrupt sustained decrease in eGFR >20% after excluding reversible causes 2
• Grade 2 or higher AKI (creatinine 2-3 times baseline) that doesn't respond to conservative management 5
• Suspected glomerulonephritis (active urinary sediment, nephritic/nephrotic syndrome) 1
• Uncertainty about etiology: heavy proteinuria, active urine sediment, absence of diabetic retinopathy in diabetics, or rapid GFR decline 4

Consider Earlier Referral (eGFR 45-60 mL/min/1.73 m²)

Refer when there is:

• Possibility of non-diabetic kidney disease: type 1 diabetes duration <10 years, persistent albuminuria without retinopathy, abnormal renal ultrasound findings, or active urinary sediment 4
• Rapid progression: eGFR decline >5 mL/min/1.73 m² per year 2
• Diabetic patients with proteinuria >1 g/day where immunosuppressive therapy may be considered 2

Common Pitfalls to Avoid

Do Not Delay Referral For:

• Late referral (defined as <12 months before anticipated need for renal replacement therapy) significantly increases morbidity, mortality, and costs 8
• Stage 4 CKD (eGFR <30 mL/min/1.73 m²) requires nephrology involvement to prepare for potential dialysis or transplantation, manage complications (anemia, bone disease, acidosis), and slow progression 1, 8

Reversible Causes Must Be Addressed First:

Before attributing elevated creatinine to chronic disease, exclude:

• Volume depletion/prerenal azotemia 6, 2
• Urinary obstruction (obtain renal ultrasound if suspected) 6, 1
• Recent nephrotoxin exposure (NSAIDs, contrast, aminoglycosides) 6, 5
• Medication-induced (ACE inhibitors/ARBs in bilateral renal artery stenosis) 7

Monitoring Frequency:

• eGFR 45-60 mL/min/1.73 m²: Monitor every 6 months 4
• eGFR 30-44 mL/min/1.73 m²: Monitor every 3 months 4
• After initiating hemodynamically active therapies: eGFR reductions >30% warrant evaluation 3
• Rapid creatinine changes (>20-30% increase): Reassess within 7 days 7

Coordination of Care

Primary care providers should continue managing cardiovascular risk factors, blood pressure control, glycemic control, and avoiding nephrotoxins even after nephrology referral, as these remain critical to slowing CKD progression 1. The nephrologist will focus on CKD-specific complications including anemia, mineral-bone disorder, metabolic acidosis, and preparation for renal replacement therapy 1.